In 3 months get your IGF-1 tested
(a) Gastrointestinal trials (Ulcerative Colitis) A Croatian research group conducted: A phase I safety study in healthy men A phase II trial of a rectal BPC-157 formulation for mildmoderate ulcerative colitis These are only available as abstracts and drug summaries , not as full peer-reviewed publications with methods, statistics, or adverse event profiles
You may lose less weight than someone who doesnt have a breast cancer diagnosis, who isnt taking active endocrine therapy, but people do lose weight, and that amount of weight may be meaningful
In some people, semaglutide and similar drugs may lower inflammation, while in others, it may affect how the immune system responds in unexpected ways
It also supports muscle maintenance during weight loss